NOTE
11 - ACCOUNTS PAYABLE AND ACCRUALS - OTHER:
SCHEDULE
OF ACCOUNTS PAYABLE AND ACCRUALS - OTHER
| | |
2026 | | |
2025 | |
| | |
June 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| | |
($ in thousands) | |
| Employees and employee institutions | |
$ | 3,135 | | |
$ | 4,925 | |
| Accrued vacation and recreation pay | |
| 716 | | |
| 430 | |
| Accrued expenses | |
| 1,016 | | |
| 1,545 | |
| Clinical trial accrual | |
| 1,184 | | |
| 1,155 | |
| Current Operating lease liabilities | |
| 1,056 | | |
| 1,066 | |
| Customer credit balances* | |
| 581 | | |
| 2 | |
| Other | |
| 304 | | |
| 334 | |
| Accounts
Payable and Accruals - Other | |
$ | 7,992 | | |
$ | 9,457 | |
| * | | Customer credit
balances primarily represent credits issued to customers in connection with the voluntary recall of CGuard Prime products (see note 1a). |
|